Your search returned 5 results.

Results
	1.	Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy? [electronic resource] by Bedewy, Ahmed M L El-Maghraby, Shereen M Producer: 20140507 In: Hematology (Amsterdam, Netherlands) vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Do baseline Cereblon gene expression and IL-6 receptor expression determine the response to thalidomide-dexamethasone treatment in multiple myeloma patients? [electronic resource] by Bedewy, Ahmed M L El-Maghraby, Shereen M Producer: 20140731 In: European journal of haematology vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. [electronic resource] by Eissa, Soheir A L Zaki, Samar A El-Maghraby, Shereen M Kadry, Dalia Y Producer: 20070614 In: Journal of the Egyptian National Cancer Institute vol. 17 Availability: No items available. Save to lists Add to cart (remove)
	4.	The prognostic value of glucocorticoid receptors for adult acute lymphoblastic leukemia. [electronic resource] by Bedewy, Ahmed M L El-Maghraby, Shereen M Kandil, Noha S El-Bendary, Waleed R Producer: 20160115 In: Blood research vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma. [electronic resource] by Bedewy, Ahmed M L Elgammal, Maha M Adel Bedewy, Magdy M L El-Maghraby, Shereen M Producer: 20131112 In: Annals of hematology vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)